Critical hepatic hemangioma in infants

Recent nationwide survey in Japan

Tatsuo Kuroda, Ken Hoshino, Shunsuke Nosaka, Yohko Shiota, Atsuko Nakazawa, Tetsuya Takimoto

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The International Society for the Study of Vascular Anomalies (ISSVA) classification divides vascular lesions into two major entities: neoplasms originating from the vascular endothelium and vascular malformations. Although this concept has been widely accepted, little has been established regarding vascular lesions in deep organs, such as infantile hepatic hemangioma (IHH). The current nationwide survey identified 19 critical infantile hemangiomas during the most recent 5 years. On histopathology all the lesions examined were neoplastic, but portovenos shunt was found histologically or clinically in some cases. High-output cardiac failure, consumption coagulopathy, and respiratory distress were the major symptoms, and treatment-resistant coagulopathy seemed to be the most reliable predictor of fatal outcome. Although steroid has been the gold standard treatment for these lesions, 25% of the patients were totally insensitive to steroids, whereas propranolol had a prompt effect in one case. For critical IHH with steroid-insensitive thrombocytopenia and prothrombin time prolongation, novel therapeutic options including beta-blocker therapy, surgery, and liver transplantation should be urgently considered as alterative treatment. The present review summarizes the results of the survey.

Original languageEnglish
Pages (from-to)304-308
Number of pages5
JournalPediatrics International
Volume56
Issue number3
DOIs
Publication statusPublished - 2014

Fingerprint

Hemangioma
Japan
Liver
Blood Vessels
Steroids
Therapeutics
Vascular Malformations
Fatal Outcome
Disseminated Intravascular Coagulation
Prothrombin Time
Vascular Endothelium
Propranolol
Thrombocytopenia
Liver Transplantation
Heart Failure
Surveys and Questionnaires
Neoplasms

Keywords

  • coagulopathy
  • high-output cardiac failure
  • infantile hepatic hemangioma
  • ISSVA classification

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Kuroda, T., Hoshino, K., Nosaka, S., Shiota, Y., Nakazawa, A., & Takimoto, T. (2014). Critical hepatic hemangioma in infants: Recent nationwide survey in Japan. Pediatrics International, 56(3), 304-308. https://doi.org/10.1111/ped.12347

Critical hepatic hemangioma in infants : Recent nationwide survey in Japan. / Kuroda, Tatsuo; Hoshino, Ken; Nosaka, Shunsuke; Shiota, Yohko; Nakazawa, Atsuko; Takimoto, Tetsuya.

In: Pediatrics International, Vol. 56, No. 3, 2014, p. 304-308.

Research output: Contribution to journalArticle

Kuroda, T, Hoshino, K, Nosaka, S, Shiota, Y, Nakazawa, A & Takimoto, T 2014, 'Critical hepatic hemangioma in infants: Recent nationwide survey in Japan', Pediatrics International, vol. 56, no. 3, pp. 304-308. https://doi.org/10.1111/ped.12347
Kuroda, Tatsuo ; Hoshino, Ken ; Nosaka, Shunsuke ; Shiota, Yohko ; Nakazawa, Atsuko ; Takimoto, Tetsuya. / Critical hepatic hemangioma in infants : Recent nationwide survey in Japan. In: Pediatrics International. 2014 ; Vol. 56, No. 3. pp. 304-308.
@article{2eb7f52514bf414e9484cab469705e40,
title = "Critical hepatic hemangioma in infants: Recent nationwide survey in Japan",
abstract = "The International Society for the Study of Vascular Anomalies (ISSVA) classification divides vascular lesions into two major entities: neoplasms originating from the vascular endothelium and vascular malformations. Although this concept has been widely accepted, little has been established regarding vascular lesions in deep organs, such as infantile hepatic hemangioma (IHH). The current nationwide survey identified 19 critical infantile hemangiomas during the most recent 5 years. On histopathology all the lesions examined were neoplastic, but portovenos shunt was found histologically or clinically in some cases. High-output cardiac failure, consumption coagulopathy, and respiratory distress were the major symptoms, and treatment-resistant coagulopathy seemed to be the most reliable predictor of fatal outcome. Although steroid has been the gold standard treatment for these lesions, 25{\%} of the patients were totally insensitive to steroids, whereas propranolol had a prompt effect in one case. For critical IHH with steroid-insensitive thrombocytopenia and prothrombin time prolongation, novel therapeutic options including beta-blocker therapy, surgery, and liver transplantation should be urgently considered as alterative treatment. The present review summarizes the results of the survey.",
keywords = "coagulopathy, high-output cardiac failure, infantile hepatic hemangioma, ISSVA classification",
author = "Tatsuo Kuroda and Ken Hoshino and Shunsuke Nosaka and Yohko Shiota and Atsuko Nakazawa and Tetsuya Takimoto",
year = "2014",
doi = "10.1111/ped.12347",
language = "English",
volume = "56",
pages = "304--308",
journal = "Pediatrics International",
issn = "1328-8067",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Critical hepatic hemangioma in infants

T2 - Recent nationwide survey in Japan

AU - Kuroda, Tatsuo

AU - Hoshino, Ken

AU - Nosaka, Shunsuke

AU - Shiota, Yohko

AU - Nakazawa, Atsuko

AU - Takimoto, Tetsuya

PY - 2014

Y1 - 2014

N2 - The International Society for the Study of Vascular Anomalies (ISSVA) classification divides vascular lesions into two major entities: neoplasms originating from the vascular endothelium and vascular malformations. Although this concept has been widely accepted, little has been established regarding vascular lesions in deep organs, such as infantile hepatic hemangioma (IHH). The current nationwide survey identified 19 critical infantile hemangiomas during the most recent 5 years. On histopathology all the lesions examined were neoplastic, but portovenos shunt was found histologically or clinically in some cases. High-output cardiac failure, consumption coagulopathy, and respiratory distress were the major symptoms, and treatment-resistant coagulopathy seemed to be the most reliable predictor of fatal outcome. Although steroid has been the gold standard treatment for these lesions, 25% of the patients were totally insensitive to steroids, whereas propranolol had a prompt effect in one case. For critical IHH with steroid-insensitive thrombocytopenia and prothrombin time prolongation, novel therapeutic options including beta-blocker therapy, surgery, and liver transplantation should be urgently considered as alterative treatment. The present review summarizes the results of the survey.

AB - The International Society for the Study of Vascular Anomalies (ISSVA) classification divides vascular lesions into two major entities: neoplasms originating from the vascular endothelium and vascular malformations. Although this concept has been widely accepted, little has been established regarding vascular lesions in deep organs, such as infantile hepatic hemangioma (IHH). The current nationwide survey identified 19 critical infantile hemangiomas during the most recent 5 years. On histopathology all the lesions examined were neoplastic, but portovenos shunt was found histologically or clinically in some cases. High-output cardiac failure, consumption coagulopathy, and respiratory distress were the major symptoms, and treatment-resistant coagulopathy seemed to be the most reliable predictor of fatal outcome. Although steroid has been the gold standard treatment for these lesions, 25% of the patients were totally insensitive to steroids, whereas propranolol had a prompt effect in one case. For critical IHH with steroid-insensitive thrombocytopenia and prothrombin time prolongation, novel therapeutic options including beta-blocker therapy, surgery, and liver transplantation should be urgently considered as alterative treatment. The present review summarizes the results of the survey.

KW - coagulopathy

KW - high-output cardiac failure

KW - infantile hepatic hemangioma

KW - ISSVA classification

UR - http://www.scopus.com/inward/record.url?scp=84901836274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901836274&partnerID=8YFLogxK

U2 - 10.1111/ped.12347

DO - 10.1111/ped.12347

M3 - Article

VL - 56

SP - 304

EP - 308

JO - Pediatrics International

JF - Pediatrics International

SN - 1328-8067

IS - 3

ER -